Clinical Trial Update: Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SAR342434 to Humalog as rapid-acting insulin in adults with type 1 diabetes mellitus using insulin glargine; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Humalog (insulin lispro)
• Insulin Glargine (insulin glargine)
• SAR342434

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2018-01-18